GSK3B and tuberculosis: From this perspective, it would be interesting to explore if the computational design of dual GSK-3β/sirtuin inhibitors could provide additional benefits by enhancing immune cell polarization and function, thereby improving disease outcomes in TB alongside conventional antibiotics.